Sivik Global Healthcare’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-75,000
Closed -$3.75M 44
2022
Q2
$3.75M Buy
+75,000
New +$3.98M 2.13% 24
2021
Q3
Sell
-60,000
Closed -$3.16M 53
2021
Q2
$3.16M Buy
+60,000
New +$3.13M 0.62% 39
2020
Q1
Sell
-150,000
Closed -$7.53M 56
2019
Q4
$7.53M Buy
150,000
+10,000
+7% +$468K 2.8% 12
2019
Q3
$6.49M Buy
140,000
+40,000
+40% +$1.73M 3.27% 10
2019
Q2
$4.33M Sell
100,000
-30,000
-23% -$1.28M 1.05% 27
2019
Q1
$5.76M Buy
+130,000
New +$5.57M 2.12% 18

Other funds holding SNY

Sivik Global Healthcare's SNY Position: Q3 2022 in Review

Sivik Global Healthcare sold out of Sanofi (SNY) in Q3 2022, closing a stake of 75,000 shares — an estimated $3.75M sold.

Sivik Global Healthcare first reported a position in SNY in Q1 2019 and held it in 6 quarters. The position peaked at $7.53M in Q4 2019. 588 funds tracked by Wall St. Rank hold SNY as of Q3 2022.

  • Sivik Global Healthcare reported no remaining Sanofi position as of Q3 2022 after selling out during the quarter.
  • Sivik Global Healthcare sold 75,000 Sanofi shares in Q3 2022, an estimated $3.75M.
  • Sivik Global Healthcare first reported a position in Sanofi in Q1 2019 and held it in 6 quarters.
  • Sivik Global Healthcare's Sanofi position peaked at $7.53M in Q4 2019.
  • 588 funds tracked by Wall St. Rank held Sanofi as of Q3 2022.

Based on Sivik Global Healthcare's 13F filing for Q3 2022, filed 4 Nov 2022.